CME Post-Test Answer Sheet and Evaluation For - Global Academy ...

For Reference only—Must be Completed Online
A CME-CERTIFIED Supplement to
Rheumatology News®
Biologic Therapies in RA:
Improving Patient Outcomes
conference highlights
CME Post-Test Answer Sheet and Evaluation Form
Release Date of Activity: October 2011 • Expiration Date of Activity for AMA PRA Credit: September 30, 2012
Estimated Time to Complete This Activity: 1.0 hour
To get instant CME credit online, go to http://uofl.me/rheum11. Upon successful completion of the online test and evaluation form,
you will be directed to a Web page that will allow you to receive your certificate of credit via e-mail. Please add chse@louisville.edu to
your e-mail “safe” list.
Type the above address into your address bar in Internet Explorer. If you are unfamiliar with what an address bar is or how to access
yours, open Internet Explorer, then hold down the control key and press the “O” key on your keyboard. A dialogue box will open—this
is where you will type the above address. After you have typed the address, click “OK” to go to the evaluation.
Once you have completed the evaluation, you will be given a password. Please be sure to write it down; you will then be able to access
your certificate. Please note, certificates will not be mailed, so be sure to print a copy for your records. If you have any questions or
difficulties, please contact the University of Louisville School of Medicine Continuing Health Sciences Education office at (502) 852-5329.
CME Questions
Instructions: For each question or incomplete statement, choose the answer or completion that is correct.
Circle the most appropriate response.
1. According to the information presented, patients who discontinue a TNF inhibitor:
A. May benefit from switching to a different TNF inhibitor
B. Do not benefit from switching to a different TNF inhibitor
C. Should not be treated with another anti-TNF agent
D. Should be switched to a different biologic agent
2. A Dutch study of treatment withdrawal showed that more patients were able to discontinue therapy when treatment was
initiated with:
A. Single-agent methotrexate
B. Combination conventional-DMARD therapy
C. Combination therapy including a TNF inhibitor
D. Combination therapy with delayed start of anti-TNF therapy
3. A study of patients with moderate disease activity at baseline showed that treatment with certolizumab pegol versus placebo:
A. Led to similar 52-week outcomes regardless of treatment
B. Was associated with a significantly higher rate of low-disease activity
C. Resulted in paradoxical acceleration of the disease process
D. Was associated with unacceptable toxicity for patients with less than severe RA
4. A comparison of two strategies to achieve RA remission showed that:
A. A TNF inhibitor achieved a significantly higher remission rates compared with intravenous steroids
B. IV steroids were superior to a TNF inhibitor at all time points
C. Remission rates did not differ significantly between the two strategies
D. Patients preferred treatment with the TNF inhibitor
5. A comparison of four different DAS-driven treatment strategies showed that:
A. Treatment to target using DAS criteria is not feasible
B. Regimens that achieve and maintain remission or low-disease activity have unacceptable toxicity
C. Treatment to target was no more effective than empiric treatment with methotrexate
D. No patient in any of the groups had radiologic progression during the study
6. Which DAS28 value assessed at 3 months demonstrated potential for predicting outcomes at 6 months?
A. Lower DAS28 score
B. Change from baseline in DAS28 score
C. DAS28 velocity
D. A & B
Biologic Therapies in RA: Improving Patient Outcomes CME Post-Test Answer Sheet and Evaluation Form 1

Biologic Therapies in RA: Improving Patient Outcomes
conference highlights
Release Date of Activity: October 2011 • Expiration Date of Activity for AMA PRA Credit: September 30, 2012
Estimated Time to Complete This Activity: 1.0 hour
EVALUATION FORM
We would appreciate your answering the following questions in order to help us plan for other activities of this type. All information is confidential.
Please print.
Name: _____________________________________________________________________________________________________
Specialty: ____________________________________________________________________________________________________
Degree: m MD m DO m PharmD m RPh m NP m RN m BS m PA m Other:_ ___________________________________________
Affiliation:____________________________________________________________________________________________________
Address:_ ____________________________________________________________________________________________________
City:_____________________________________________________________State: ________________________ Zip: ____________________
Telephone:_______________________________________________________Fax:_______________________________________________
E-mail: _____________________________________________________________________________________________________
Signature:_ ___________________________________________________________________________________________________
CME Credit Verification
I verify that I have spent _______ hour(s)/_______ minutes of actual time working on this CME activity. No more than 1.0 CME credit will be
issued for this activity.
COURSE EVALUATION: Gaps
This activity was created to address the professional practice gaps
listed below, please respond regarding how much you agree or disagree
that the following gaps were met:
• Current information from basic science research and clinical trials
to determine the optimal choice of disease-modifying antirheumatic
drugs (DMARDs) for patients with rheumatoid arthritis (RA) and
psoriatic arthritis (PsA).
• Clinical expertise in diagnosing RA early.
• The inflammatory mechanisms that are involved in the
pathophysiology of rheumatic diseases, including RA and PsA.
• Diagnosing and treating patients with RA promptly enough to avoid
structural joint damage.
• Optimal treatment choices for their patients with RA, PsA, and
other rheumatic diseases.
Did participating in this educational activity improve your KNOWLEDGE
in the professional practice gaps that are listed above?
Strongly Agree Agree Somewhat Agree Disagree Strongly Disagree
1 2 3 4 5
Please elaborate on your answer.____________________________
____________________________________________________
____________________________________________________
____________________________________________________
Did participating in this educational activity improve your COMPETENCE
in the professional practice gaps that are listed above?
Strongly Agree Agree Somewhat Agree Disagree Strongly Disagree
1 2 3 4 5
Please elaborate on your answer.____________________________
____________________________________________________
____________________________________________________
Did participating in this educational activity improve your
PERFORMANCE in the professional practice gaps that are
listed on the left?
Strongly Agree Agree Somewhat Agree Disagree Strongly Disagree
1 2 3 4 5
Please elaborate on your answer.____________________________
____________________________________________________
____________________________________________________
Please identify a change that you will implement into practice
as a result of participating in this educational activity (new
protocols, different medications, etc)_______________________
____________________________________________________
____________________________________________________
How certain are you that you will implement this change?
Strongly Agree Agree Somewhat Agree Disagree Strongly Disagree
1 2 3 4 5
What topics do you want to hear more about, and what issue(s) in
your practice will they address?___________________________
____________________________________________________
____________________________________________________
Were the patient recommendations based on acceptable practices
in medicine? m Yes m No
If no, please explain which recommendation(s) were not based on
acceptable practices in medicine?____________________________
____________________________________________________
____________________________________________________
Do you think the articles were without commercial bias?
m Yes m No
If no, please list the article(s) that were biased._________________
____________________________________________________
____________________________________________________ ____________________________________________________
The University of Louisville thanks you for your participation in this CME activity. All information provided improves the scope and purpose of our programs and your patients’ care.
CME INSTRUCTIONS: This educational supplement provides 1.0 free AMA PRA Category 1 Credit. Access http://uofl.me/rheum11 and print your certificate online.
Biologic Therapies in RA: Improving Patient Outcomes CME Post-Test Answer Sheet and Evaluation Form Copyright © 2011 Elsevier Inc. 2